View in EDS

Biweekly carboplatin plus nab-paclitaxel with concurrent radiotherapy followed by durvalumab consolidation for unresectable locally advanced non-small cell lung cancer: a real-world retrospective cohort study.

Saved in:
Bibliographic Details
Title: Biweekly carboplatin plus nab-paclitaxel with concurrent radiotherapy followed by durvalumab consolidation for unresectable locally advanced non-small cell lung cancer: a real-world retrospective cohort study.
Authors: Nunomura Y; Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan., Tanaka H; Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan., Oyama S; Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan., Miura T; Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan., Odagiri H; Department of Respiratory Medicine, Aomori Prefectural Central Hospital, Aomori, Japan., Kobori Y; Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan., Chubachi K; Department of Respiratory Medicine, Aomori Prefectural Central Hospital, Aomori, Japan., Ishidoya M; Department of Respiratory Medicine, Aomori Prefectural Central Hospital, Aomori, Japan., Sakamoto H; Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan., Makiguchi T; Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan., Miura D; Department of Respiratory Medicine, Aomori Prefectural Central Hospital, Aomori, Japan., Morimoto T; Department of Respiratory Medicine, Aomori Prefectural Central Hospital, Aomori, Japan., Hasegawa Y; Department of Respiratory Medicine, Aomori Prefectural Central Hospital, Aomori, Japan., Taima K; Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan., Tasaka S; Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Source: Translational lung cancer research [Transl Lung Cancer Res] 2026 May 31; Vol. 15 (5), pp. 126. Date of Electronic Publication: 2026 May 26.
Publication Type: Journal Article
Journal Info: Publisher: Pioneer Bioscience Publishing Company Country of Publication: China NLM ID: 101646875 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2218-6751 (Print) Linking ISSN: 22186751 NLM ISO Abbreviation: Transl Lung Cancer Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2218-6751
DOI:10.21037/tlcr-2026-1-0162